Cart
sales@molnova.com
SB269970 HCl
CAS No. 261901-57-9
SB269970 HCl ( SB-269970A )
Catalog No. M17459 CAS No. 261901-57-9
SB269970 HCl, a hydrochloride salt form of SB-269970, is a 5-HT7 receptor antagonist (pKi of 8.3) and exhibits >50-fold selectivity against other receptors.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 113 | In Stock |
|
| 25MG | 243 | In Stock |
|
| 50MG | 426 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSB269970 HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionSB269970 HCl, a hydrochloride salt form of SB-269970, is a 5-HT7 receptor antagonist (pKi of 8.3) and exhibits >50-fold selectivity against other receptors.
-
DescriptionSB269970 HCl, a hydrochloride salt form of SB-269970, is a 5-HT7 receptor antagonist (pKi of 8.3) and exhibits >50-fold selectivity against other receptors.
-
SynonymsSB-269970A
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
Recptor5-HT7
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number261901-57-9
-
Formula Weight388.95
-
Molecular FormulaC18H28N2O3S·HCl
-
Purity98%
-
SolubilityDMSO : ≥ 30 mg/mL; 77.13 mM
-
SMILESCl.CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hagan JJ, et al. Br J Pharmacol, 2000, 130(3), 539-548.
molnova catalog
related products
-
SKF-96365 hydrochlor...
SKF-96365, an SOCE inhibitor, exhibits potent anti-neoplastic activity by inducing cell-cycle arrest and apoptosis in colorectal Y cells.
-
MDR-652
MDR-652 is a highly specific and efficacious agonist of nonpungent transient receptor potential vanilloid 1 (TRPV1) with Ki value of 11.4 nM and 23.8 nM for hTRPV1 and rTRPV1 respectively and EC50s for hTRPV1 and rTRPV1 are 5.05 and 93 nM respectively.
-
JNJ-17203212
A potent, selective and orally bioavailable TRPV1 receptor antagonist with IC50 of 65 nM and 102 nM for hTRPV1 and rTRPV1, respectively.
